Liu P, Zhu Z, Ma J, Wei L, Han Y, Shen E, Tan X, Chen Y, Cai C, Guo C, Peng Y, Gao Y, Liu Y, Huang Q, Gao L, Li Y, Jiang Z, Wu W, Liu Y, Zeng S, Li W *, Feng Z *，Shen H *. Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma. Front Immunol. 2022 Sep 9; 13: 951529.
发布时间：2023-03-08
点击次数：
是否译文：否
上一条： YJ Fu, SS Liu, RM Rodrigues, Y Han, C Guo, ZW Zhu, Y He, B Mackowiak, DC Feng, B Gao *, S Zeng *, H Shen *. Activation of vasoactive intestinal polypeptide type-I receptor suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism. Intl J Biol Sci. 2022 Jul 4; 18(11): 4341-4356.
下一条： QQ Huang #, Y Han #, Edward Shen, ZY Feng,YH Peng, L Gao, Y Gao, YT Liu, W Li, P Liu, C Guo, S Zeng, CJ Cai *, H Shen *. MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. iScience. 2022 Sep 10; 26(1):105095